Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Ferdy Lejeune"'
Autor:
Ferdy Lejeune
Publikováno v:
Melanoma research. 28(6)
Autor:
P R Dunbar, Vincenzo Cerundolo, Daniel E. Speiser, Pedro Romero, Jean-Charles Cerottini, Katharina Fleischhauer, Ferdy Lejeune, Danila Valmori, Danielle Liénard, Mikael J. Pittet
Publikováno v:
Journal of Experimental Medicine, vol. 190, no. 5, pp. 705-15
The Journal of Experimental Medicine
The Journal of Experimental Medicine
Using fluorescent HLA-A*0201 tetramers containing the immunodominant Melan-A/MART-1 (Melan-A) tumor-associated antigen (Ag), we previously observed that metastatic lymph nodes of melanoma patients contain high numbers of Ag-experienced Melan-A-specif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a34eb4ae630c7bc379ec6c696b8b211f
https://doi.org/10.1084/jem.190.5.705
https://doi.org/10.1084/jem.190.5.705
Autor:
Jan Willem Coebergh, Sandra Collette, Ulrich R. Kleeberg, Ferdy Lejeune, Alexander M.M. Eggermont, Tamar Nijsten, Esther de Vries, Arjen Joosse, Stefan Suciu
Publikováno v:
Journal of Clinical Oncology, 30(18), 2240-2247. American Society of Clinical Oncology
Purpose Several studies observed a female advantage in the prognosis of cutaneous melanoma, for which behavioral factors or an underlying biologic mechanism might be responsible. Using complete and reliable follow-up data from four phase III trials o
Autor:
Didier Roulin, Danielle Lienard, Ferdy Lejeune, P. Bady, O. Gugerli, Ariane Boubaker, Maurice Matter, L. Bron
Publikováno v:
European Journal of Surgical Oncology (EJSO). 34:673-679
To confirm the accuracy of sentinel node biopsy (SNB) procedure and its morbidity, and to investigate predictive factors for SN status and prognostic factors for disease-free survival (DFS) and disease-specific survival (DSS).Between October 1997 and
Autor:
Jean-Charles Cerottini, Nathalie Rufer, Ferdy Lejeune, Pedro Romero, Verena Rubio-Godoy, Daniel E. Speiser, Donata Rimoldi, Arthur M. Krieg, Danielle Liénard
Publikováno v:
Journal of Clinical Investigation. 115:739-746
The induction of potent CD8+ T cell responses by vaccines to fight microbes or tumors remains a major challenge, as many candidates for human vaccines have proved to be poorly immunogenic. Deoxycytidyl-deoxyguanosin oligodeoxynucleotides (CpG ODNs) t
Autor:
Pedro Romero, Ferdy Lejeune, Daniel E. Speiser, Philippe Guillaume, Danielle Liénard, Jean-Charles Cerottini, Donata Rimoldi, Mikael J. Pittet, Immanuel F. Luescher
Publikováno v:
Seminars in Cancer Biology. 13:461-472
Immunotherapy of melanoma is aimed to mobilize cytolytic CD8+ T cells playing a central role in protective immunity. Despite numerous clinical vaccine trials, only few patients exhibited strong antigen-specific T-cell activation, stressing the need t
Publikováno v:
European Journal of Surgical Oncology (EJSO). 28:875-890
Many treatments have been proposed for non-resectable primary or secondary hepatic cancer but the results have generally been disappointing. Isolated Hepatic Perfusion (IHP) was first attempted four decades ago but it gained acceptance only recently,
Autor:
Pedro Romero, Frédéric Lévy, Verena Rubio-Godoy, Mikael J. Pittet, Jean-Charles Cerottini, Maha Ayyoub, Philippe Guillaume, Valérie Dutoit, Donata Rimoldi, Daniel E. Speiser, Olivier Michielin, Danielle Liénard, Pascal Batard, Immanuel F. Luescher, Alfred Zippelius, Pierre-Yves Dietrich, Ferdy Lejeune, Nathalie Rufer, Danila Valmori
Publikováno v:
Immunological Reviews. 188:81-96
Some cancer patients mount spontaneous T- and B-cell responses against their tumor cells. Autologous tumor reactive CD8 cytolytic T lymphocyte (CTL) and CD4 T-cell clones as well as antibodies from these patients have been used for the identification
Autor:
Ferdy Lejeune
Publikováno v:
Melanoma Research. 27:73-73
Autor:
Bin B. R. Kroon, Ferdy Lejeune, Danielle Liénard, Mario Santinami, Franco Di Filippo, Alexander M.M. Eggermont, Harald J. Hoekstra
Publikováno v:
Surgical Oncology Clinics of North America. 10:821-832
Isolated limb perfusion (ILP) is a method of cancer treatment allowing the administration of high doses of anticancer agents in a limb surgically isolated from systemic circulation. By using continuous leakage monitoring and using the drug melphalan,